
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
CROs must take advantage of Internet-based technologies to remain competitive and relevant in the industry.
almost 25 years ago
Bioterrorism Threat Shines Spotlight on Drug Manufacturingalmost 25 years ago
International Employment Survey 2001almost 25 years ago
Outsourcing Outlookalmost 25 years ago
A Comprehensive Approach to Pharmaceutical Engineering Training